| Influenza A(H1N1)pdm09 virus resistance to baloxavir, oseltamivir and sialic acid mimetics in single and dual therapies : Insights from human airway epithelia and murine models | Antiviral research |  | | 2025 | 9 | 48 |
|
| A synthetic multivalent lipopeptide derived from Pam3CSK4 with irreversible influenza inhibition and immuno‐stimulating effects | Small | | | 2024 | 172 | 169 |
|
| Antiviral properties of trans-δ-viniferin derivatives against enveloped viruses | Biomedicine & pharmacotherapy | | | 2023 | 261 | 163 |
|
| An anti-influenza combined therapy assessed by single cell RNA-sequencing | Communications biology | | | 2022 | 294 | 277 |
|
| In vitro assessment of Influenza A virus antiviral resistance against multiple treatments | |  | | 2021 | 84 | 0 |
|
| Interferon lambda delays the emergence of influenza virus resistance to oseltamivir | Microorganisms | | | 2021 | 273 | 164 |
|
| Methylene Blue has a potent antiviral activity against SARS-CoV-2 and H1N1 influenza virus in the absence of UV-activation in vitro | Scientific Reports | | | 2021 | 467 | 564 |
|
